The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective

Over the past decade, the development of high-efficacy disease-modifying therapies (DMTs) has been responsible for more effective management of relapsing-remitting multiple sclerosis (RRMS). However, the gaps in optimal care for this complex disease remain. Alemtuzumab (Lemtrada®) is a highly effica...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Neurol Disord
Huvudupphovsmän: Alroughani, Raed, Van Wijmeersch, Bart, Al Khaboori, Jabber, Alsharoqi, Isa Ahmed, Ahmed, Samar F., Hassan, Ali, Inshasi, Jihad, Krieger, Derk W., Shakra, Mustafa, Shatila, Ahmed Osman, Szolics, Miklos, Khallaf, Mohamed, Ezzat, Aly
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2020
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498833/
https://ncbi.nlm.nih.gov/pubmed/32973927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420954119
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk